Pancras C. Wong

12.8k citations

156 papers · 10.2k indexed · 4 hit papers · h-index 46

Cardiology and Cardiovascular Medicine top 0.1%
Molecular Biology top 1%
Endocrinology, Diabetes and Metabolism top 0.5%
Organic Chemistry top 2%
Hematology top 1%

Co-authors: Andrew T. Chiu Ruth R. Wexler David J. Carini Pieter B.M.W.M. Timmermans William F. Herblin John V. Duncia A.L. Johnson Roger Smith
Topics: Blood Coagulation and Thrombosis Mechanisms (55 papers)Renin-Angiotensin System Studies (38 papers)Receptor Mechanisms and Signaling (37 papers)
Cited by: Cardiology and Cardiovascular Medicine Internal Medicine Endocrinology, Diabetes and Metabolism
Journals: Circulation Blood Stroke
Partner nations: United States Germany Sweden

In The Last Decade

Pancras C. Wong

156 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin II receptors and angiotensin II receptor antagonists.

1993 1.6k citations Pancras C. Wong, Andrew T. Chiu et al. profile →
Identification of angiotensin II receptor subtypes

1989 705 citations Andrew T. Chiu, William F. Herblin et al. Biochemical and Biophysical Research Communications profile →
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

2008 490 citations Nirmala Raghavan, Donald Pinto et al. profile →
Nonpeptide angiotensin II receptor antagonists

1991 465 citations Pieter B.M.W.M. Timmermans, Pancras C. Wong et al. profile →

Peers

Countries citing papers authored by Pancras C. Wong

Since Specialization

Citations

This map shows the geographic impact of Pancras C. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pancras C. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pancras C. Wong more than expected).

Fields of papers citing papers by Pancras C. Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pancras C. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pancras C. Wong. The network helps show where Pancras C. Wong may publish in the future.

Co-authorship network of co-authors of Pancras C. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Pancras C. Wong. A scholar is included among the top collaborators of Pancras C. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pancras C. Wong. Pancras C. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys 2021 ·Research and Practice in Thrombosis and Haemostasis ·Pancras C. Wong,Mimi L. Quan	6
2	Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice 2020 ·Journal of Pharmacological and Toxicological Methods ·(unknown),John Allocco,Melissa Yarde,Pancras C. Wong,Xiuying Ma	15
3	Abstract 13794: An Orally-Active Small-Molecule Antagonist of the Platelet Protease-Activated Receptor-4, BMS-986141, Prevents Aeterial Thrombosis With Low Bleeding Liability in Cynomolgus Monkeys 2017 ·Circulation ·Pancras C. Wong,Carol A. Watson,(unknown),Jacques Banville,Ruth R. Wexler,E. Scott Priestley,Anne Marinier,Michel Bouvier,David Gordon,(unknown),Jing Yang	2
4	The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys 2015 ·Journal of Thrombosis and Thrombolysis ·Pancras C. Wong,Carol A. Watson,Earl J. Crain	24
5	Abstract 9916: Potent Antithrombotic Effect of a Small-molecule, Reversible and Direct Inhibitor of Factor XIa With Minimum Bleeding Time Effect In Rabbit Models of Arterial Thrombosis and Hemostasis 2013 ·Circulation ·Pancras C. Wong,Mimi L. Quan,Carol A. Watson,Earl J. Crain,Ruth R. Wexler,Dietmar Seiffert	1
6	Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor 2013 ·Bioorganic & Medicinal Chemistry Letters ·E. Scott Priestley,(unknown),Jinglan Zhou,Jiacheng Zhou,Eddine Saiah,Robert V. Stanton,Leslie A. Robinson,Joseph M. Luettgen,Anzhi Wei,(unknown),Robert M. Knabb,Pancras C. Wong,Ruth R. Wexler	23
7	Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Xiaojun Zhang,Peter W. Glunz,Wen Jiang,(unknown),(unknown),Frank Barbera,(unknown),Alan R. Rendina,Anzhi Wei,(unknown),Karen A. Rossi,Joseph M. Luettgen,Pancras C. Wong,Robert M. Knabb,Ruth R. Wexler,E. Scott Priestley	7
8	Metabolism, pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban in rabbits 2009 ·Journal of Thrombosis and Thrombolysis ·Donglu Zhang,Kan He,Nirmala Raghavan,Lifei Wang,Earl J. Crain,Bing He,Baomin Xin,Joseph M. Luettgen,Pancras C. Wong	17
9	Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits 2008 ·Journal of Thrombosis and Haemostasis ·Pancras C. Wong,Carol A. Watson,Earl J. Crain	39
10	Abstract 631: Nonpeptide Factor XIa (FXIa) Inhibitor. In vitro Kinetic Evaluation and in vivo Studies of BMS-262084 on Arterial Thrombosis and Hemostasis in Rabbits 2006 ·Circulation ·Pancras C. Wong,William A. Schumacher,Carol A. Watson,Earl J. Crain,Martin L. Ogletree,Alan R. Rendina	3
11	Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer X. Qiao,Xuhong Cheng,Joanne M. Smallheer,Robert A. Galemmo,(unknown),Donald Pinto,Daniel L. Cheney,Kan He,Pancras C. Wong,Joseph M. Luettgen,Robert M. Knabb,Ruth R. Wexler,Patrick Y. S. Lam	18
12	Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mimi L. Quan,Christopher D. Ellis,(unknown),Ann Y. Liauw,Patrick Y. S. Lam,Karen A. Rossi,Robert M. Knabb,Joseph M. Luettgen,Matthew Wright,Pancras C. Wong,Ruth R. Wexler	17
13	ANTITHROMBOTIC ACTIONS OF SELECTIVE INHIBITORS OF BLOOD COAGULATION FACTOR Xa IN RAT MODELS OF THROMBOSIS 1996 ·Thrombosis Research ·Pancras C. Wong,Earl J. Crain,(unknown),Carol A. Watson,(unknown)	37
14	Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position. 1994 ·Bioorganic & Medicinal Chemistry Letters ·Joseph B. Santella,John V. Duncia,Carol L. Ensinger,(unknown),David J. Carini,Ruth R. Wexler,Andrew T. Chiu,Pancras C. Wong,Pieter B.M.W.M. Timmermans	14
15	New perspectives in angiotensin system control. 1993 ·PubMed ·Pieter B.M.W.M. Timmermans,Pancras C. Wong,Andrew T. Chiu,William F. Herblin,Roger Smith	21
16	Pharmacology of Nonpeptide Angiotensin II Receptor Antagonists 1992 ·The Annual Review of Pharmacology and Toxicology ·Roger Smith,Andrew T. Chiu,Pancras C. Wong,William F. Herblin,Pieter B.M.W.M. Timmermans	224
17	Effects of DuP 753 on Proximal Nephron and Renal Transport 1991 ·American Journal of Hypertension ·Martin G. Cogan,Ming-Hong Xie,Fuying Liu,Pancras C. Wong,Pieter B.M.W.M. Timmermans	20
18	Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist 1991 ·European Journal of Pharmacology ·Pancras C. Wong,S. William Tam,William F. Herblin,Pieter B.M.W.M. Timmermans	18
19	In Vivo Pharmacology of DuP 753 1991 ·American Journal of Hypertension ·Pancras C. Wong,William A. Price,Andrew T. Chiu,John V. Duncia,David J. Carini,Ruth R. Wexler,A.L. Johnson,Pieter B.M.W.M. Timmermans	99
20	Identification of angiotensin II receptor subtypesbreakdown → 1989 ·Biochemical and Biophysical Research Communications ·Andrew T. Chiu,William F. Herblin,Dale E. McCall,Robert Ardecky,David J. Carini,John V. Duncia,Lori J. Pease,Pancras C. Wong,Ruth R. Wexler,A.L. Johnson,Pieter B.M.W.M. Timmermans	705

About Pancras C. Wong

Pancras C. Wong is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 156 papers that have together received 10.2k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (55 papers), Renin-Angiotensin System Studies (38 papers) and Receptor Mechanisms and Signaling (37 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.6k citations), Internal Medicine (995 citations) and Endocrinology, Diabetes and Metabolism (2.3k citations). Pancras C. Wong has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Andrew T. Chiu, Ruth R. Wexler, David J. Carini, Pieter B.M.W.M. Timmermans, William F. Herblin, John V. Duncia, A.L. Johnson, Roger Smith, William A. Price and P.B.M.W.M. Timmermans. Their work appears in journals such as Circulation, Blood and Stroke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact